It has been demonstrated that rhein can restore chemosensitivity in the SMMC-7721 liver cancer cell line to doxorubicin and in pancreatic cancer cells to EGFR inhibitors by inhibiting mitochondrial energy metabolism and the STAT3 pathway, respectively [21,60]. This evidence concerns the gene EGFR and familial pancreatic carcinoma.